DNA interstrand cross-linking efficiency and cytotoxic activity of novel cadmium(II)-thiocarbodiazone complexes

Chembiochem. 2001 Feb 2;2(2):119-23. doi: 10.1002/1439-7633(20010202)2:2<119::AID-CBIC119>3.0.CO;2-5.


We have prepared mono- and binuclear complexes of Zn(II) and Cd(II) with bis(2-pyridyl aldehyde) thiocarbodiazone (H(2)L(1)) and bis(methyl 3-pyridyl ketone) thiocarbodiazone (H(2)L(2)). Cytotoxicity data against the ovarian tumor cell line A2780cisR (acquired resistance to cisplatin) indicate that the mononuclear complex Cd/H(2)L(2) (1) and the binuclear complex Cd(2)/H(2)L(1) (4) are able to circumvent cisplatin resistance and that their cytotoxic activity does not substantially vary after depletion of intracellular levels of glutathione. Moreover, DNA binding studies show that complexes 1 and 4 have higher efficiency than cisplatin at forming DNA interstrand cross-links in both naked pBR322 plasmid and A2780cisR cellular DNA. Interestingly, the thiocarbodiazone ligands alone do not show the biological properties of complexes 1 and 4. Altogether these results suggest that DNA interstrand cross-link formation by compounds 1 and 4 might be related with their cytotoxic activity in cisplatin-resistant cells. We think that compounds 1 and 4 may represent a novel structural lead for the development of cadmium cytotoxic agents capable of improving antitumor activity in cisplatin-resistant tumors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cisplatin / pharmacology
  • Cross-Linking Reagents / chemistry*
  • DNA / chemistry*
  • Glutathione / pharmacology
  • Humans
  • Indicators and Reagents
  • Ligands
  • Plasmids / chemistry
  • Thiosemicarbazones / chemistry*
  • Thiosemicarbazones / pharmacology*
  • Tumor Cells, Cultured


  • Antineoplastic Agents
  • Cross-Linking Reagents
  • Indicators and Reagents
  • Ligands
  • Thiosemicarbazones
  • DNA
  • Glutathione
  • Cisplatin